Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,360 INR | -3.09% | -7.10% | +14.00% |
18/03 | Rainbow Children's Medicare Limited Approves Appointment of Adarsh Kancharla as Non-Executive Director | CI |
08/03 | Rainbow Children's Medicare Expands Capacity of Hyderabad, India Hospital | MT |
Summary
- The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 61% by 2026.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 61.2 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.00% | 170.52Cr | C- | ||
-19.34% | 1.65TCr | B+ | ||
+5.41% | 1.25TCr | B | ||
+4.64% | 1.17TCr | B+ | ||
+2.21% | 1.01TCr | B+ | ||
+28.85% | 871.3Cr | B | ||
-3.46% | 756.88Cr | A- | ||
+18.60% | 713.5Cr | D | ||
+4.85% | 668.21Cr | B- | ||
+44.78% | 453.87Cr | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- RAINBOW Stock
- Ratings Rainbow Children's Medicare Limited